Indications And Dose
Hypertension not adequately controlled by telmisartan alone ▶BY MOUTH ▶Adult: (consult product literature)
PDF page 212
Drug reference
Hypertension not adequately controlled by telmisartan alone ▶BY MOUTH ▶Adult: (consult product literature)
PDF page 212
→Appendix 1: angiotensin-II receptor antagonists. thiazide diuretics
PDF page 212
There can be variation in the licensing of different medicines containing the same drug. Tablet ▶Telmisartan with hydrochlorothiazide (Non-proprietary) Hydrochlorothiazide 12.5 mg,Telmisartan 40 mg Telmisartan 40mg / Hydrochlorothiazide 12.5mg tablets | 28 tablet P £13.61 DT = £13.61 Hydrochlorothiazide 25 mg,Telmisartan 80 mg Telmisartan 80mg / Hydrochlorothiazide 25mg tablets | 28 tablet P £17.00 DT = £15.67 Hydrochlorothiazide 12.5 mg,Telmisartan 80 mg Telmisartan 80mg / Hydrochlorothiazide 12.5mg tablets | 28 tablet P £17.00 DT = £16.83 ▶Actelsar HCT (Actavis UK Ltd) Hydrochlorothiazide 12.5 mg,Telmisartan 40 mg Actelsar HCT 40mg/12.5mg tablets | 28 tablet P £13.61 DT = £13.61 Hydrochlorothiazide 25 mg,Telmisartan 80 mg Actelsar HCT 80mg/25mg tablets | 28 tablet P £17.00 DT = £15.67 Hydrochlorothiazide 12.5 mg,Telmisartan 80 mg Actelsar HCT 80mg/12.5mg tablets | 28 tablet P £17.00 DT = £16.83 ▶MicardisPlus (Boehringer Ingelheim Ltd) Hydrochlorothiazide 12.5 mg,Telmisartan 40 mg MicardisPlus 40mg/12.5mg tablets | 28 tablet P £13.61 DT = £13.61 Hydrochlorothiazide 12.5 mg,Telmisartan 80 mg MicardisPlus 80mg/12.5mg tablets | 28 tablet P £17.00 DT = £16.83 ▶MicardisPlus 80/25 (Boehringer Ingelheim Ltd) Hydrochlorothiazide 25 mg,Telmisartan 80 mg MicardisPlus 80mg/25mg tablets | 28 tablet P £17.00 DT = £15.67 ▶Tolucombi (Consilient Health Ltd) Hydrochlorothiazide 12.5 mg,Telmisartan 40 mg Tolucombi 40mg/12.5mg tablets | 28 tablet P £13.61 DT = £13.61 Hydrochlorothiazide 25 mg,Telmisartan 80 mg Tolucombi 80mg/25mg tablets | 28 tablet P £17.00 DT = £15.67 Hydrochlorothiazide 12.5 mg,Telmisartan 80 mg Tolucombi 80mg/12.5mg tablets | 28 tablet P £17.00 DT = £16.83 eiiii F 185
PDF page 212
(consult product literature)
First-line fragment. Read the complete Indications and Dose section above.
PDF page 212